Follow MIMS on Twitter

For instant updates on prescribing-related issues, you can now follow MIMS on Twitter.

Twitter is a website that allows people to communicate by posting quick, frequent updates, or ‘tweets’, of 140 characters or fewer. The MIMS editorial team ‘tweet’ key prescribing-related developments as they occur, keeping you updated in between our monthly print editions and email bulletins.

MIMS tweets cover drug launches and discontinuations, licence extensions and safety updates, as well as MIMS-related news on subscription offers, conferences, new MIMS resources and other developments.

If you haven’t yet registered, Twitter is free and easy to join. If you already have a Twitter account, just follow @mimsonline to start seeing MIMS updates in real-time. Why not follow our sister website GPonline.com at the same time?

How to… Reach patients via social media

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...